Colon

    .

     

    Microscopic Colitis

    • Definition:
      • Histologic inflammation in endoscopically normal-appearing colon.
      • Features of fat malabsorption, and vitamin deficiencies should not be seen.
      • Mild weight loss, dehydration
    • Pathology:
      • Intra-epithelial lymphocytes in colonic mucosa.
      • Two types: Lymphocytic colitis, and collagenous colitis (collagenous band)
    • Causes:
      • Medications
        • Drugs That May Cause Microscopic Colitis

           

          High Likelihood

          Acarbose, Aspirin, Lansoprazole (possibly other PPIs), 

          NSAIDs, Ranitidine, Sertraline, Ticlopidine

          Intermediate Likelihood

          Carbamazepine, Flutamide, Lisinopril, Levodopa

          with benserazide, Paroxetine, Simvastatin

          Low Likelihood

          Cimetidine, Gold Salts

          Source: Beaugerie L, Pardi DS. Review article: drug-induced

          microscopic colitis - proposal for a scoring system and review

          of the literature. Aliment Pharmacol Ther. 2005;22(4):277-284. PMID: 16097993

      • Systemic Disease
    • Clinical Features:
      • Hallmark: "Painless watery diarrhea, no bleeding"
      • Often referred for chronic large-volume diarrhea.
      • **nocturnal stools**.
      • Not as much abdominal pain.
    • Diagnosis:
      • Colonoscopy with random biopsies.
    • Treatment:
      • Review Medications (over counter + rx)
      • R/O Celiac Disease
      • Medical Therapy:
        • Mild Disease:
          • Loperamide
          • Diphenoxylate
        • Moderate Disease
          • Bismuth subsalicylate
        • Severe Disease:
          • Budesonide (Delayed-release)
          • Stopping budesonide has high recurrence rates > 80%.  Sometimes may need to continue low-dose budesonide or steroid sparing (azathioprine, etc..)

    Mesenteric Ischemia

    Acute

    • SEVERE PAIN out of proportion on exam
    • Small bowel or colon can be affected.  (Colon is most common)
    • Symptoms:
      • Main symptom: PAIN (from mild/crampy to severe surgical emergency)
      • Suspect if PAIN on history, but abdominal exam shows less tenderness than expected.
      • ===> AKA "Pain Out of Proportion To Physical Exam"
    • Causes:
      • Embolic: Usually embolic phenomenon - often SMA (either atrial embolism or thrombus in ventricle)
      • Non-Occlusive Ischemia:
        • Can get through hypoperfusion (i.e. splancnic vasoconstriction, or hypotension after acute MI)
        • "Non-Occlusive mesenteric ischemia"
    • Risk Factors:
      • >50yo, underlying cardiovascular disease
      • If young (vasoactive med - cocaine use, tryptans etc.)
    • Investigations:
      • Labs: Elevated WBC, Lactate, metabolic acidosis (suggests bowel compromise)
      • Abdo Xray: can be normal if early, but can show dilated loops of bowel, and "Thumbprinting" of bowel or R colon.
      • Ultrasound: Limited role, only for proximal origin of vessels.
      • CT: "Intestinal pneumotosis" (air in bowel wall)
        • Thickening of the bowel wall (Crohn's can also cause thickening)
        • (CT can be normal early, and findings can show necrotic bowel)
      • CT/MR-based Angiography
        • Better diagnose acute ischemia (earlier) - find vascular distribution.
        • Cannot treat.
      • Angiography: **Gold Standard**
        • Invasive, but best accuracy, and can intervene to re-open. 
    • Management:
      • Resuscitation  (electrolytes, acidosis management, NG decompression)
      • D/C meds associated with vasoconstriction (ergots, cocaine, vasopressors, tryptans, etc..)
      • Antibiotics (high frequency of sepsis)
      • Anticoagulants: (Controversial) - usually for mesenteric vein thrombosis
        • Usually post-surgery (x7-10 days improves survival, decreases recurrence)
        • Typically bridge to warfarin x3-6mo
      • If No Peritonitis:  (usually endovascular, but can be open)
        • Interventional Radiology (Angiography - gold standard to diagnose)
          • Embolectomy/thrombectomy & revascularization (surgery or endovascular stent)
          • Local thrombolysis for incomplete embolectomy or distal embolization.
          • Papaverine (Phosphodiesterase inhibitor) - can be given at time of angiography to help open arteries.
      • If Peritoneal Signs:
        • Surgery  (to resect necrotic bowel)
      • Surgery also if there is a high index of concern for AMI despite negative imaging studies
        • Surgical revascularization is also definitive treatment for non-occlusive mesenteric ischemia.

     

    Chronic

    • Aka "Intestinal Angina" 
    • Caused by intestinal atherosclerosis
    • Symptoms:
      • Abdominal pain 30min after eating. (Diversion of small bowel blood flow to stomach)
        • Food avoidance - Can cause "siderphobia" - fear of eating
      • Eventually: Pain without eating
      • Rarely cause intestinal infarction
    • Diagnosis:
      • Imaging + clinical history.
      • Doppler ultrasound (Screening test, cannot confirm Dx, esp poor if obsese)
      • MR + CT angiography more sensitive + specific
      • Abnormal study warrants --> confirmatory splanchnic angiography
    • Treatment:
      • Surgical revascularization (like CABG)
      • Percutanous angioplasty +/- stenting (if poor surgical candidates)
        • Short-term success is high, but long-term recurrence is high (compared to surgical bypass)

     

    Colonic Ischemia

    • Vast majority of intestinal ischemia (75%) is colonic ischemia
      • Severity from mild transient reversible colitis --> gangrene fulminant colitis (high mortality)
    • Most common sites: "watershed regions" at splenic flexture + retrosigmoid junction (desc. colon + sigmoid)
      • Rectum has dual supply, rarely affected.
    • Causes:
      • Arterial - Hypoperfusion (decreased output - arrhythmias, sepsis, shock, thrombotic, embolic - cholesterl arterial etc...)
      • Drug-induced
        • Cocaine, digoxin, estrogen, pseudoephedrine
      • Post-operative
        • CABG, Abdominal aortic surgery
      • Vasculitis - SLE
      • Hypercoagulable state - Protein C/S deficiency, AT3, FVL, etc..
    • Symptoms:
      • Acute onset mild crampy abdo pain, with tenderness on exam over affected colonic region.
        • Can get colonic bleeding, if it's a few days of onset.
    • Diagnosis:
      • Abdomen Xray  or CT (can be normal), look for Thumbprinting
      • Flexible Sigmoidoscopy or Colonoscopy (***Gold Standard***)
    • Treatment:
      • Supportive Care
        • IV Fluids
        • Broad spectrum abx.
      • Treat causative agent (stop drugs, etc..)
      • Peritoneal findings / shock requiring colectomy is very rare
        • (usally patients recover well)

    Toxic Megacolon

    • Diagnosis:
      • Diagnostic Criteria for Toxic Megacolon

         

        1.  Radiologic Evidence of Colonic Distension

        (Usually cited >6cm colon, usually transverse)

         

        2.  PLUS (3 of following)

        - Fever > 38°C

        - Heart Rate > 120 bpm

        - Neutrophils > 10,500/uL

        - Anemia

         

        3.  PLUS (ONE of following)

        - Dehydration

        - Altered sensorium

        - Electrolyte Disturbances

        - Hypotension

    • Management:
      • Resuscitation & Monitoring (NPO!)
      • NG tube decompression (only if vomiting, or gas-filled stomach)
      • Consider broad-spectrum antibiotics (ulcerated colonic mucosa can cause invasion of bacteria)
        • cipro flagyl, pip-tazo, carbapenems.
        • If concerned for C.Diff --> PO vanco + IV flagyl (or fidaxomicin)
      • Consider IV Steroids in Inflammatory Colitis
        • Does not increase rate of colonic perforation, but can mask it. 
        • Taper after resolution.
      • Surgery!
        • If no improvement in 24-48hrs of conformed dx --> indication for surgery

    Notes on Constipation

    • Slowly introduce fibre, fluids.
    • PEG is superior to other osmotic agents (more frequency, form).
    • Magnesium antacids helpful, but careul if impaired renal function.
    • Methylnaltrexone - chronic opioids
    • Biofeedback therapy (dyssynnergic defecation, pelvic floor dysfunction)

     

    Diverticular Disease

    • Colonic diverticulosis is common:
      • 40% by age 60,  60% by age 80
    • Distal colon most often affected (sigmoid + descending)  (in Asians --> more proximal + Cecal)
    • 1 to hundreds of diverticuli (5-10mm in diameter)
    • Pathophysiology:
      • Anatomic factors (weakness in vaso-recta penetration of colon wal)
      • Motility factors (poor haustral contractions)
      • Dietary causes (Decreased fiber intake)

     

    Diverticulitis

    • 1 in 5 at least one episode.
    • Clinical Features:
      • Leukocytosis, Fever, LLQ pain
      • Other: Loss of appatite, nausea, vomiting, dysuria, abdo mass, guarding, rebound tenderness
    • DDx: Appendicitis, crohn's, colorecal cancer, ischemic colitis, ovarian cyst (abscess/torsion), ectopic pregnancy.
    • Diagnosis:
      • If not obvious clinically:
        • Abdominal-Pelvic CT is test of choice
      • Colonoscopy or Flexible Sigmoidoscopy relatively contraindicated --> procedure induced perforation
    • Management
      • Natural History / Management of Diverticulitis

         

        Subgroup

        Features

        Management

        Isolated, uncomplicated

        Solitary episode of acute diverticulitis

        Antibiotics, bowel rest, analgesia

        Recurrent, uncomplicated

        Multiple discrete episodes of acute diverticulitis

        Surgical resection on a case-by-case basis

        Complicated

        Acute diverticulitis with abscess, fistula, obstruction, perforation, or stricture

        - Antibiotics

        - Percutaneous drainage

        - Endoscopic stent 
        (temporizing measure, to make surgery elective)

        - Surgical resection

        Smoldering

        Acute diverticulitis with ongoing, chronic symptoms

        Antibiotics, surgical resection

        - Abx should cover gram-negative rods and anaerobic bacteria.

            - Outpatient abx for mild symptoms

            - Inpatient IV therapy for severe symptoms or complicated disease

        Source: MKSAP 16 - Gastroenterol Clin North Am. 38(3). Touzios JG, Dozois EJ. Diverticulosis and acute diverticulitis; 513-525.


         
      • Once acute diverticulitis has resolved --> Need to scope to r/o other dx (Crohn's, Adenocarcinoma)
      • Surgery offered to immunocompromized patients even after one episode (high risk of complications)
      • NOTE: Nuts, popcorn, corn, etc... does not cause diverticulitis (from large cohort studies)
    • Outpatient Management of Mild Diverticulitis
    1. Liquid Diet
    2. Broad Spectrum Antibiotics
    3. Analgesia

    ALARM Features requiring Colonoscopy

    • Blood in stool
    • Weight loss
    • Sudden change in bowel habits
    • FHx of Colon Ca
    • New Constipation age >50

     

    Colorectal Cancer

    • Worldwide 3rd in cancer incidence and 4rth in mortality
    • Black patients have higher colorectal cancer incidence + mortality.
    • Risk Factors:
      • Environmental:
        • Red meat consumption (Especially when charred - high temperature cooking)
        • Cigarette Smoking
        • Alcohol >30g/day (3 drinks/day)
      • Predisposing Conditions:
        • BMI > 30 (growth hormone mediated)
        • IBD (duration important, and amount of colitis - pancolitis vs. left-only)
        • Famiy History (esp if <50yo)
        • Type II DM (high insulin + insulin-like growth factors) - 30% higher risk.
        • Cholecystectomy (changes in bile secretion)
        • Ureterosigmoidostomy (500x)
      • Nonsyndromic Family History
        • Complex, ask about polyps too (relationship of family members, age of dx, number of relatives)
    • Reducing Risk:
      • Physical Activity
      • Calcium supplements --> modest favourable effect (but toxicity common)
      • Diets high in fruits, vegetables, fiber --> reduced risk (prevention benefits not demonstrated)
      • Folate --> limited data for potential benefit (query accelerated tumor growth)

     

    Types of Polyps

    • NOTE: Serrated Colorectal Polyps (WHO classification):

      • 1.  Hyperplastic Polyps 

      • 2.  Sessile Serrated Polyps

      • 3.  Traditional Serrated Adenomas

    • Polyp Type Prevalence Appearance Malignancy Risk Notes
      Hyperplastic Polyps VERY COMMON Sessile/Flat NO!  
      Sessile Serrated Adenoma COMMON Sessile/Flat   15% of colorectal ca starts as SSP
               No Dysplasia     LOW  
               Dysplasia     YES  
      Traditional Serrated Adenomas     YES  
    • See "high risk screening" section

    Colon Cancer Surveillance Guidelines

    Summary

    • If Average Risk -->
      • Screen at 50yo (90% of colon ca. occur after age 60)
        • Colonoscopy q10y
        • Flex sig q5y
        • FOBT q1y
      • Two categories:
        • Detection of pre-malignant CRC
          • Flex-sig, Barium Enema, Colonoscopy, CT colonography
        • Detection of CRC
          • Fecal Assays
    • If Higher Risk:
      • 1st deg. relative with CRC  --> screen at 40yo or 10y prior to diagnosis q5y Colonoscopy
      • IBD involving 1/3 of colon --> Screen 8y post-diagnosis, colonoscopy q1-2y
        • If PSC diagnosed --> Screen right away, q1y

     

    Polyp Follow-Up

    • 1 or more adenomas detected during CRC screening evaluation --> increased risk of advanced CRN
      • Low Risk (1-2 adenomas, <1cm, tubular morphology, and low-grade dysplasia) --> colonoscopy in 5 years
      • High Risk (≥3 adenomas, ≥1cm, villous morphology, or high-grade dysplasia) --> colonoscopy in 3y
      • IF >10 ademonas --> repeat colonoscopy in <3y, consider hereditary syndrome.
      • LARGE adenomas --> repeat in 2-6mo to ensure complete resection.
      • IF small, hyperplastic, rectal polyps (not hyperplastic polyposis syndrome) --> average screening.
    • AGA Guidelines 2012:

     

    Screening - Average Risk

    • Colorectal Cancer Screening Guidelines for Average-Risk Persons

       

      Screening Option

      ACP

      ACS-USMSTF-ACR

      USPSTF

      Screening Intervala

      Guaiac fecal occult blood testing

      Recommended

      Recommended if >50% sensitivity for CRC

      Recommended

      1 year

      Fecal immunochemical test

      Recommended

      Recommended if >50% sensitivity for CRC

      Recommended

      1 year

      Stool DNA test

      Recommended

      Recommended if >50% sensitivity for CRC

      Not recommended owing to insufficient evidence

      Uncertain

      Flexible sigmoidoscopy

      Recommended

      Recommended if sigmoidoscope is inserted to 40 cm of the colon or to the splenic flexure

      Recommended, with fecal occult blood test every 3 years

      5 years

      CT colonography

      Uncertain

      Recommended, with referral for colonoscopy if polyps ≥6 mm in diameter are detected

      Not recommended owing to insufficient evidence

      5 years

      Colonoscopy

      Recommended

      Recommended

      Recommended

      10 years

      Barium enema

      Not recommended

      Recommended, but only if other endorsed options are not available

      Not recommended

      5 years

      ACP = American College of Physicians

      ACS-USMSTF-ACR = American Cancer Society, U.S. Multi-Society Task Force on Colorectal Cancer, and American College of Radiology;

      USPSTF = U.S. Preventive Services Task Force.

      Reprinted from Gastroenterology. 138(6). Lieberman D. Progress and challenges in colorectal cancer screening and surveillance; 2115-2126. 


       
    • Exam Notes
      Guaiac fecal occult blood testing (GFOBT)

      Changes color in presence of peroxidase:

      • Found in human blood
      • Found in incompletely cooked meat + other dietary sources

      Proper collection: 2 samples from 3 consecutive stools (6 total) - at home, mail to clinical lab.

      • Must use "High Sensitivity" GFOBT test

      RCTs: Statistically significant reductions in CRC (incidence 17-20% reduction, mortality 15-33% reduction)

      • Limitations:
        • Low sensitivity for advanced adenomas, diet/medication interacttions (FP + FN), annual testing, needs diagnostic f/u if positive.
        • If any positive ---> colonoscopy
      Fecal Immunohistochemical Test (FIT Assay)

      Antibodies directed against human globin protein (improves specificity over GFOBT)

      Advantages:

      • No Pre-test dietary restrictions
      • Single test is ok
      Stool DNA Test (sDNA testing)

      - Unlike FOBT< sDNA assays target molecular alterations directly from the lesion.

      - Entire stool specimen (30g minimum) must be submitted

      - Two prospective screening studies --> moderate sensitivity for (25-58%) for CRC.

      - Not routinely available in US.

      Flexible Sigmoidoscopy

      - Lower colorectum, up to 60cm.

      - Limited bowel prep required (2 enemas), no conscious sedation (can have sedation though).

      - If find adenomas any size or polyps larger than 5mm --> should get full colonoscopy.

      - Screening benefits only in examined segment (mortality down 60%)

      - Proximal neoplasia more common in black patients and older women --> often need direct colonoscopy for those pts.

      - Bowel perforation <1 in 20,000 exams.

      CT Colonography

      - Entire colorectum, + limited extra-colonic structures

      - Dietary restrictions + oral contrast required.

      - During exam - small catheter placed to insufflate colon with room air or CO2 (no sedation)

      - Compared with colonoscopy, estimated Sens >90% for CRC, and 85-93% for polyps ≥1cm

      - Bowel perforation possible <1:10,000 exams

      Colonoscopy

      - Entire colorectum

      - Dietary restrictions + full prep required prior  + Sedation

      - Theraputic polypectomy can be done. 

      - q10years if ideal visualization 

          - If poor or suboptimal prep --> should repeat ASAP before planning longer term suveillance

      Miss rates are 5% for CRC, 2-12% for polyps ≥1cm, ≥20% polyps ≥6mm

      - Risks:

         - bleeding (2-6:1000), bowel perforation (1:1000)

     

    Screening - Increased Risk

    • Colorectal screening guidelines provided...
    • NOTE: Serrated Colorectal Polyps (WHO classification):

      • 1.  Hyperplastic Polyps 

      • 2.  Sessile Serrated Polyps

      • 3.  Traditional Serrated Adenomas

      • Polyp Type Pre-Malignant? Notes
        Hyperplastic Polyps NO!  
        Sessile Serrated Polyps YES 15% of colorectal ca starts as SSP
        Traditional Serrated Adenomas YES
        •  

         
    • Colorectal Cancer Surveillance for Patients at Increased Risk

       

      Patient Group

      Preferred Test

      Onset

      Surveillance Interval

      Other Considerations

      Inflammatory Bowel Disease (as long as 1/3 of distal colon is involved)

      UC, pancolitis

      Colonoscopy

      IBD duration >8 years

      1-2 years

       

      UC, distal colitis

      Colonoscopy

      IBD duration >8 years

      1-2 years

       

      UC, proctitis

      Colonoscopy

      IBD duration >8 years

      10 years

       

      Crohn disease, ≥1/3 of colon involved

      Colonoscopy

      IBD duration >8 years

      1-2 years

       

      With PSC

      Colonoscopy

      At PSC diagnosis

      1 year

       

      Nonsyndromic Family History

      1 first-degree relative with CRC

      Colonoscopy

      Age 40 years or age 10 years before youngest age at CRC diagnosis in the family, whichever is younger

      5 years

       

      Hereditary Cancer Syndromes

      Lynch syndrome

      Colonoscopy

      Age 20-25 years

      1-2 years

      Transvaginal ultrasound or endometrial aspirate at age 25-30 years, repeat every 1 year (women)

      Urine cytology at onset of CRC screening, repeat every 1 year

      Upper endoscopy screening may be offered in families with gastric cancer

      Familial CRC type X

      Colonoscopy

      Age 5-10 years before youngest age at CRC diagnosis in the family

      3-5 years

       

      Familial adenomatous polyposis, classic

      Flexible sigmoidoscopy

      - Only one with flex sig

      (distal bowel 

      in classic)

      Age 10-12 years

      1 year

      Abdominal ultrasound and serum α-fetoprotein, age 0-6 years, repeat every 1 year

      Upper endoscopy (with side-viewing examination of the duodenal papilla) when CRN detected or by age 25 years, repeat every 1-3 years

      Palpation of thyroid gland, repeat every 1 year

      Familial adenomatous polyposis, attenuated

      Colonoscopy

      Age 5-10 years before youngest age at CRC diagnosis in the family

      1 year

       

      MYH-associated polyposis

      Colonoscopy

      Age 25-30 years

      3-5 years

      Upper endoscopy (with side-viewing examination of the duodenal papilla) at age 30-35 years, repeat every 3-5 years

      Peutz-Jeghers syndrome

      Colonoscopy

      Age 25 years

      2-3 years

      Upper endoscopy and small-bowel radiography at age 10 years, repeat every 2 years

      Testicular exam at age 10 years, repeat every 1 year (men)

      Pelvic exam with cervical smear at age 20 years, repeat every 1 year (women)

      Mammography at age 25-35 years, repeat every 1 year (women)

      Juvenile polyposis

      Colonoscopy

      Age 12 years

      3 years

      Upper endoscopy by age 15 years, then repeat every 1-3 years

      Hyperplastic polyposis

      Colonoscopy

      Age 40 years

      5 years

       

      CRC = colorectal cancer; CRN = colorectal neoplasia (adenoma or adenocarcinoma); IBD = inflammatory bowel disease; PSC = primary sclerosing cholangitis; UC = ulcerative colitis.

      Source: MKSAP 16

     

    IBD Screening

    • British BSG Guidelines 2010
      • NOTE: No Canadian, unsure if US - could not find. Dr. Pritchett recommended BC guidelines.
    • UKguidelines.png

    •  

    Hereditary Non-Polyposis Colorectal Ca

    • Most common type of hereditary colorectal cancer. (2-3% of cases)
    • Autosomal dominant.
    • Lifetime risk of colorectal Ca is 80% (mean dx 44yo)
    • Types of Malignancies:
      • Colorectal Cal (Lifetime risk 80%)
      • Endometrial Cancer (30-60%) - 2nd most common
      • Gastric
      • Biliary tract
      • Urinary tract, Ovarian, Small bowel cancer.
    • Diagnosis:
      • Pedigree analysis +/- molecular testing
      • Amsterdam criteria III
      • Criteria for Hereditary Nonpolyposis Colorectal Cancer Screening

         

        Amsterdam Criteria II

        Suspect HNPCC if all criteria are met. Used to identify families likely to represent HNPCC.

        ≥3 relatives with an HNPCC-associated cancer

        ≥2 successive generations affected

        ≥1 first-degree relative of at least 2 other cancer cases

        ≥1 cancer diagnosed before age 50 years

        Revised Bethesda Guidelines

        Proceed with microsatellite instability testing if any criterion is met. Used to select colorectal cancer cases for molecular analyses of the DNA mismatch repair system.

        Colorectal cancer diagnosed in a patient less than 50 years of age

        Presence of synchronous, metachronous colorectal or other HNPCC-associated tumors, regardless of age

        Colorectal cancer with the MSI-H (Microsatalite instability high) histology diagnosed in a patient less than 60 years of age

        Colorectal cancer diagnosed in one or more first-degree relatives with an

        HNPCC-related tumor, with one of the cancers diagnosed under age 50 years

        Colorectal cancer diagnosed in two or more first- or second-degree relatives with HNPCC-related tumors, regardless of age

         Gastroenterology. 116(6). Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC; 1453-1456.

         Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261-268

      •  
      • Others:

    • Syndrome Notes

      Hereditary Non-Polyposis Colorectal Ca

      (HNPCC)

      - Most common

      - 80% risk of lifetime colorectal cancer

      Familial Adenomatous Polyposis (FAP)

      - APC gene (autosomal dominant) mutations

      - Hundreds to thousands of polyps (16yo mean) --> almost all get CRC (mean 39yo)

      - Duodenal carcinoma (4-12%), Gastric Ca, papillary thyroid ca, etc...

      - Mutational analysis to confirm diagnosis

      Attenuated familial adenomatous 

      polyposis (AFAP)

      - <100, proximal colorectal adenomas

      - Cumulative CRC (70%) rather than 100% in FAP

      MYH-Associated Polyposis

      - Heterozygous or homozygous mutation in MYH gene (base excision repair)

      - Autosomal recessive

      - Resembles AFAP, and broader extra-colonic neoplasia

      - Genetic testing not yet routinely performed.

      Peutz-Jeghers Syndrome

      - Autosomal Dominant 

      - Mucocutaneous melanocytic macules, usually peri-oral and buccal mucosal and 

      GI hemartomatous polyps  (abdo pain, bleeding obstruction, intususception)

      - Genetic test exists

      Juvenile Polyposis Syndrome  
      Hyperplastic Polypsosi (HPP)
    Tag page (Edit tags)
    • No tags
    Page statistics
    33351 view(s), 27 edit(s) and 49343 character(s)

    Comments

    You must login to post a comment.

    Attach file

    Attachments

    FileSizeDateAttached by 
     agaGuidelines.png
    No description
    60.12 kB16:19, 12 May 2016apavelActions
     UKguidelines.png
    No description
    64.64 kB16:34, 12 May 2016apavelActions